Spero Therapeutics, Inc. Other Receivables
Spero Therapeutics, Inc. (SPRO) had Other Receivables of $44.00 thousand as of 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Notes
us-gaap:OtherReceivables · last filed 2026-05-13
- 2026-03-31: Other Receivables $44.00K.
- 2025-12-31: Other Receivables $28.00K.
- 2025-09-30: Other Receivables $1.59M.
- 2025-06-30: Other Receivables $2.46M.
| Period end | Other Receivables | Other Receivables as first filed |
|---|---|---|
| 2026-03-31 | $44.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $28.00K 10-Q · filed 2026-05-13 | |
| 2025-09-30 | $1.59M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $2.46M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $668.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $3.08M 10-K · filed 2026-03-26 | |
| 2024-09-30 | $2.70M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $4.73M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | $5.02M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $1.54M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $2.99M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $2.09M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $1.86M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $1.08M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $914.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.56M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | $1.62M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $2.64M 10-K · filed 2023-03-30 | $2.28M 10-K · filed 2022-03-31 |
| 2021-09-30 | $2.24M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $1.85M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $8.55M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $5.33M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $7.07M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $4.03M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $2.72M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $7.76M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $5.01M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $2.07M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $456.00K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $376.00K 10-K · filed 2020-03-16 | |
| 2018-09-30 | $332.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $794.00K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $1.22M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $1.01M 10-K · filed 2019-03-14 | |
| 2017-09-30 | $537.00K 10-Q · filed 2017-12-14 | |
| 2016-12-31 | $304.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 |